NEW REVIEW: The Novelty of mRNA Viral Vaccines and Potential Harms
➨ https://www.mdpi.com/2571-8800/6/2/17
A scoping review by Matthew Halma, Jessica Rose, and myself has been published. Thank you to my wonderful co-authors!
In this review, we take a look at the platform used in the novel mRNA vaccines, not primarily the expressed antigen. We examine previous studies of RNA-based delivery by a lipid nanoparticle (LNP).
We also call for access to all related study and pharmacovigilance data to be granted to independent data analysts and scientists. Existing findings need to be made widely available and discussed openly, given the initiatives to establish multi-billion dollar mRNA programmes to forever change vaccine strategy.
Please do read and share:
https://www.mdpi.com/2571-8800/6/2/17
Follow:
➨
@DrTessLawrie
